Knee osteoarthritis pain relief – and massive weight loss – from new GLP-1

Two Phase 3 clinical trials that involved more than 1,000 adults have significantly strengthened the case for Eli Lilly's experimental GLP-1-based drug retatrutide to gain FDA approval for both weight loss and relief from knee osteoarthritis (OA).Continue ReadingCategory: Obesity, Illnesses and conditions, Body and MindTags: GLP-1 receptor agonists, Weight Loss, clinical trials, Experimental, Drug development, Arthritis, Healthy aging, Obesity, Eli Lilly